Dr. Harsha Rajasimha, Founder & CEO of Jeeva Informatics Solutions, has been a disruptor for quite some time due to personal and professional experiences. In this episode, we uncover how he has utilized his experiences and education to bring disruption into the pharmaceutical and healthcare industry by listening to all stakeholders involved in the process of clinical trials.

Key Takeaways:

• Some people do not live through the process of clinical trials to receive the appropriate care needed for a cure. 
• It is vital to remain empathetic to the customer and have the ability to imagine being in their shoes and feeling their pain. 
• The possibility of expediting that due to FDA approving virtual clinical trials, which has been seen during our current pandemic, is not only possible but more beneficial for bringing drugs to market to those who are needing them sooner. 
• There are 7,000+ rare diseases affecting over 350M people globally, and even more who have chronic and complex conditions.
• Money isn’t the barrier prohibiting drugs from coming to market. It is finding those who fit the criteria along with their enrollment process and retention.
• The biggest problem with clinical trials is the failure to identify the right patient, having them understand and enroll in the trial, and their ability to comply, whether it be due to lack of technology and other logistical problems they encounter.
• There are no shortcuts and those who opt to go down that path end up without a solution to their problem.

Links:

• LinkedIn: linkedin.com/in/harsharajasimha
• Jeeva Trials LinkedIn: https://www.linkedin.com/company/jeevatrials
• Company website: https://www.jeevatrials.com/ 
• IndoUSrare: https://www.indousrare.org/
• IndoUSrare LinkedIn: https://www.linkedin.com/company/indo-us-rare
• Email: [email protected] 

See omnystudio.com/listener for privacy information.